Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Paediatric Inflammatory Multisystem Syndrome is a rare but serious condition characterized by severe inflammation in different parts of the body, including the heart, lungs, kidneys, and brain. It typically occurs in children weeks after a COVID-19 infection.
read more about paediatric inflammatory multisystem syndrome ...The disorder is linked to the body's immune system overreacting weeks after the initial infection has passed. This exaggerated immune response causes massive, widespread inflammation in multiple organs, leading to symptoms resembling Kawasaki disease or toxic shock. The condition is not an active infection, but a post-infectious hyper-immune response that requires immediate intervention to protect vital organ function.
Symptoms include a persistent, high fever that lasts for several days, severe abdominal pain, diarrhea, and vomiting. Other signs include a widespread skin rash, redness in the eyes, and a feeling of extreme lethargy, signaling systemic distress. The combination of prolonged fever and multi-organ involvement distinguishes this condition and necessitates urgent administration of powerful anti-inflammatory therapies.
Diagnosis requires urgent blood tests to check for extremely high levels of inflammatory markers. Treatment is administered in a hospital intensive care unit and involves intravenous immunoglobulin and corticosteroids to quickly suppress the systemic inflammation.
Paediatric Inflammatory Multisystem Syndrome directly impacts eye health, as conjunctival injection (severe, non-purulent redness of the eyes) is a common symptom. The inflammation affects the vessels on the eye's surface, making the eyes appear extremely red and swollen, which serves as a notable diagnostic indicator.
While most children recover fully with prompt treatment, potential long-term effects include heart damage (aneurysms of the coronary arteries) due to the severity of the initial inflammation. Follow-up cardiac care is necessary to monitor for these delayed complications.
No, the syndrome is not contagious. It is an internal immune reaction that occurs weeks after the initial infection has passed.
Yes, the acute inflammatory phase is manageable with medication, and most children make a full recovery.
No, this is a distinct, new syndrome, but it shares many clinical features with Kawasaki disease.
If your child has a persistent high fever and "Strawberry Tongue" or bloodshot eyes without discharge, seek emergency care. The "Conjunctive Injection" (red eyes) is a key diagnostic marker for PIMS. Early IVIG treatment is necessary to protect the child's heart from inflammation.
CDC. MIS-C (PIMS) Information (cdc.gov). 2024.
NHS. PIMS Overview (nhs.uk). 2023.
RCPCH. PIMS-TS Clinical Guidance (rcpch.ac.uk). 2024.
Mayo Clinic. MIS-C Symptoms (mayoclinic.org). 2025.